How Foreign Reference Pricing Embeds Valuations And Risks Undermining Global Innovation Jason Shafrin,Richard Xie,andLouis P. Garrison, Jr. June 24, 2026

https://www.healthaffairs.org/content/forefront/import-price-import-threshold-foreign-reference-pricing-embeds-valuations-and-risks?utm_campaign=34032557-Health%20Affairs%20Sunday%20Update%202026&utm_medium=email&_hsenc=p2ANqtz-_issIK9IBjfLeM6_erjx6IbEK5fbSJmXCXKsFMObZ58Dl1h5EM4wupXdxbqDgKUInyxMHWjSlgt8I7oyaS6nSRtxTXCg&_hsmi=425789085&utm_content=425789085&utm_source=hs_email Foreign reference pricing frameworks often differ from the way the US has historically valued medical innovation. A more sustainable approach would be to define and apply US-specific measures of value and to invest in generating evidence around value.